Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Depreciation and Depletion (2024 - 2025)

Cytosorbents (CTSO) has disclosed Depreciation and Depletion for 2 consecutive years, with $300000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion changed 0.0% year-over-year to $300000.0, compared with a TTM value of $1.1 million through Sep 2025, changed N/A, and an annual FY2024 reading of $1.3 million, up 8.2% over the prior year.
  • Depreciation and Depletion was $300000.0 for Q3 2025 at Cytosorbents, up from $294300.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $457800.0 in Q2 2024 and bottomed at $241262.0 in Q4 2024.